Emergent BioSolutions Inc. Common Stock (NY:EBS)

6.900 +0.570 (+9.00%)

Delayed Quote Updated: 12:46 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Emergent BioSolutions Inc. Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

19 20 Next >

Emergent BioSolutions (EBS) Q2 2023 Earnings Call Transcript ↗

August 09, 2023

EBS earnings call for the period ending June 30, 2023.

Via The Motley Fool

Emergent BioSolutions Reports Financial Results for Second Quarter 2023

August 08, 2023

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions Announces Strategic Steps to Strengthen Core Business and Financial Position

August 08, 2023

From Emergent BioSolutions

Via GlobeNewswire

Caterpillar, Oshkosh, AudioCodes And Other Big Stocks Moving Higher On Tuesday ↗

August 01, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling around 70 points on Tuesday. Here are some big stocks recording gains in today’s session. American Superconductor Corporation (NASDAQ: AMSC)...

Via Benzinga

Why Emergent BioSolutions Stock Dived by 9% Today ↗

June 27, 2023

Investors didn't greet news of the CEO's departure warmly.

Via The Motley Fool

Is Emergent BioSolutions Stock a Buy Now? ↗

June 09, 2023

The deluge of bad news seems to be over, and a recovery could be in the works.

Via The Motley Fool

Down 75%, Can Emergent BioSolutions Turn Things Around? ↗

June 07, 2023

Has the stock finally bottomed out?

Via The Motley Fool

Why Aaron's Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 01, 2023

Gainers Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) shares gained 188.8% to $4.13. The stock is now on the Regulation SHO "threshold security" list.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

July 31, 2023

Via Benzinga

What 4 Analyst Ratings Have To Say About Emergent BioSolutions ↗

May 31, 2023

Via Benzinga

Why Emergent Biosolutions Stock Is Surging After The Close ↗

July 31, 2023

Emergent Biosolutions Inc (NYSE: EBS) shares are trading higher in Monday's after-hours session after the company was awarded a 10-year contract for

Via Benzinga

Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola

July 31, 2023

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions to Release Second Quarter 2023 Financial Results and Conduct Conference Call on August 8, 2023

July 25, 2023

From Emergent BioSolutions

Via GlobeNewswire

Potential Delay In iPhone 15 Debut Could Impact Apple's Margins, Meta's Threads App Faces User Exodus, Microsoft CEO Satya Nadella's Earnings Exceed $1B: Today's Top Stories ↗

July 21, 2023

New York Times

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

July 28, 2023

Friday's session saw 59 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 21, 2023

Via Benzinga

Why Emergent BioSolutions Shares Are Trading Higher By 16%; Here Are 20 Stocks Moving Premarket ↗

July 21, 2023

Gainers BioNexus Gene Lab Corp (NASDAQ: BGLC) shares surged 50.1% to $7.31 in pre-market trading. BioNexus Gene Lab reported pricing of $5 million public offering and uplisting to the Nasdaq Capital...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

July 21, 2023

It's the final day of trading this week and we're starting it with a breakdown of the biggest pre-market stock movers for Friday!

Via InvestorPlace

Emergent BioSolutions' Two-Dose Anthrax Vaccine Secures FDA Nod; Shares Jump ↗

July 21, 2023

The FDA approved Emergent BioSolutions Inc's (NYSE: EBS) anthrax vaccine for adults

Via Benzinga

Emergent BioSolutions Receives U.S. FDA Approval of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use

July 20, 2023

From Emergent BioSolutions

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Wednesday ↗

July 05, 2023

Wednesday's session saw 43 companies set new 52-week lows.

Via Benzinga

Emergent BioSolutions Announces CEO Transition

June 27, 2023

From Emergent BioSolutions

Via GlobeNewswire

Better Recovery-Story Buy: Emergent BioSolutions or Invitae? ↗

June 26, 2023

Both of these stocks have plummeted more than 50% over the past year.

Via The Motley Fool

Bavarian Nordic Beefs Up Chikungunya Vaccine Race With Valneva With Encouraging Late-Stage Trial Data ↗

June 20, 2023

Bavarian Nordic A/S's (OTC: BVNRY) phase 3 chikungunya virus vaccine (CHIKV VLP (PXVX0317) clinical trial has hit its primary endpoint in

Via Benzinga

Nasal-Spray Millionaire: Indivior's Opvee Nasal Spray Gets FDA Green Light for Opioid Overdose Treatment ↗

May 23, 2023

The FDA has approved Indivior PLC's (OTC: INVVY) Opvee (nalmefene) nasal spray for the emergency treatment of opioid overdose in adults and pediatric patients aged 12 years and older.

Via Benzinga

Why Emergent BioSolutions Stock Inched Slightly Higher Today ↗

May 15, 2023

Investors approved, if not enthusiastically, their company's latest asset sale.

Via The Motley Fool

Emergent BioSolutions Finalizes Sale of Travel Health Business to Bavarian Nordic

May 15, 2023

From Emergent BioSolutions

Via GlobeNewswire

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 25, 2023 at 9:00am EDT

May 11, 2023

From Emergent BioSolutions

Via GlobeNewswire

Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

May 12, 2023

Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,...

Via Benzinga

Emergent BioSolutions (EBS) Q1 2023 Earnings Call Transcript ↗

May 10, 2023

EBS earnings call for the period ending March 31, 2023.

Via The Motley Fool

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.